SPARC-1 [COVID-19]

• Research type

  Research Study

• Full title

  SARS-nCoV Pediatric AKI Registry and Collaborative

• IRAS ID

  283155

• Contact name

  Rajit Basu

• Contact email

  rajit.basu@choa.org

• Sponsor organisation

  Children's Healthcare of Atlanta

• Duration of Study in the UK

  0 years, 2 months, 30 days

• Research summary

  This study is an observational registry of children with or suspected to have SARS CoV2 admitted to pediatric intensive care units. This registry will help describe the prevalence, rate and severity of AKI in children with SARS CoV2 across the world. The registry will be developed using a point prevalence methodology. On 8 consecutive Wednesdays (i.e., once a week) from April through June, data collection will occur in “real-time” to estimate a weekly point prevalence of AKI and RRT, the operational definition of “patients under investigation” (PUIs) will be used to identify the denominator of patients to be studied. The PUIs will be cohorted into SARS CoV2 test positive, test negative, test pending, or test unavailable. The primary aim of this study is to deliver a global, objective data driven analysis of the burden of AKI in PUIs who are admitted to the pediatric intensive care unit.

• REC name

  North East - Tyne & Wear South Research Ethics Committee

• REC reference

  20/NE/0136

• Date of REC Opinion

  11 May 2020

• REC opinion

  Further Information Favourable Opinion